The activation of EPOR in melanoma was thought to promote tumor progression and contributed to survival of tumor cells (39); inhibition of EPOR gene expression in non-small cell lung cancer (NSCLC) reduced the growth of NSCLC cells under hypoxia (40). This evidence concerns the gene EPOR and neoplasm.